Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bharat Aggarwal
Imatinib Mesylate Resistance Through BCR-ABL Independence in Chronic Myelogenous Leukemia
Cancer Research
Cancer Research
Oncology
Related publications
Contribution of BCR-ABL Kinase Domain Mutations to Imatinib Mesylate Resistance in Philadelphia Chromosome Positive Malaysian Chronic Myeloid Leukemia Patients
Hematology Reports
Hematology
Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
Cathepsin B Release After Imatinib-Mediated Lysosomal Membrane Permeabilization Triggers BCR–ABL Cleavage and Elimination of Chronic Myelogenous Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Arginine Butyrate Downregulates P210 BCR-Abl Expression and Induces Apoptosis in Chronic Myelogenous Leukemia Cells
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Detection of Single Nucleotide Insertion of BCR/ABL Region in Imatinib-Resistant Human Myelogenous Leukemia SR-1 Cells
Experimental & Molecular Medicine
Prognostic Significance of Micro RNA 150 Marker in BCR-ABL Positive Chronic Myeloid Leukaemia Patients on Imatinib Mesylate
International Journal of Contemporary Pediatrics
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
Imatinib Mesylate Suppresses Cytokine Synthesis by Activated CD4 T Cells of Patients With Chronic Myelogenous Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
